Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic Dermatitis

Abstract Introduction Efficacy of upadacitinib has been assessed in trials including Measure Up 1 (NCT03569293), Measure Up 2 (NCT03607422), and Heads Up (NCT03738397). Measure Up 1 and 2 assessed efficacy of upadacitinib 30 mg and upadacitinib 15 mg against placebo, while Heads Up assessed efficacy...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	April W. Armstrong, H. Chih-Ho Hong, Brian M. Calimlim, Marric G. Buessing, Marjorie M. Crowell, Jonathan I. Silverberg
Format:	Artigo
Sprog:	Inglês
Udgivet:	Adis, Springer Healthcare 2024-07-01
Serier:	Dermatology and Therapy
Fag:	Upadacitinib Dupilumab Atopic dermatitis Indirect treatment comparison Skin clearance Pruritus
Online adgang:	https://doi.org/10.1007/s13555-024-01240-x
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!